EVC
IRD

Eidelman Virant Capital’s Opus Genetics, Inc. Common Stock IRD Stock Holding History

Eidelman Virant Capital’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		$51K Hold
25,000
– – 0.04% 163
2022
Q2 		$48K Buy
+25,000
New +$48K 0.03% 174